MB

MPM BioImpact Portfolio holdings

AUM $611M
1-Year Est. Return 29.61%
This Quarter Est. Return
1 Year Est. Return
+29.61%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$375M
AUM Growth
-$122M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
38
New
Increased
Reduced
Closed

Top Buys

1
+$17.2M
2
+$11.6M
3
+$9.11M
4
MORF
Morphic Holding, Inc. Common Stock
MORF
+$4.58M
5
VKTX icon
Viking Therapeutics
VKTX
+$3.6M

Top Sells

1
+$47.8M
2
+$38.6M
3
+$23.9M
4
EWTX icon
Edgewise Therapeutics
EWTX
+$5.52M
5
KALV icon
KalVista Pharmaceuticals
KALV
+$1.77M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$4.58M 1.22%
+200,000
27
$3.97M 1.06%
5,095,912
28
$3.92M 1.05%
255,323
29
$3.6M 0.96%
347,332
+65,000
30
$3.6M 0.96%
+325,000
31
$1.37M 0.37%
326,921
32
$1.29M 0.34%
319,670
-1
33
– –
-1,214,662
34
– –
-2,377,031
35
– –
-712,798
36
– –
-31,747
37
– –
-234,478
38
– –
-1,003,406
1
2